Clinical Trials Browser

Naltrexone × 1 year × Clear all

NCT07224009 2026-03-02

Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT05968690 2025-09-18

Naltrexone and Propranolol Combined With Immunotherapy

Phase 1 Recruiting

Melanoma, Skin Neoplasms

NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Active not recruiting

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias